More than 83% of U.S. employees are experiencing mental health issues, according to research Lyra Health conducted in 2020 in partnership with the National Alliance of Healthcare Purchaser Coalitions. Lyra Health Now Valued at $4.6B After Latest Fundraising Additionally, 40% of workers feel employers don't support their mental health. January 21, 2022. The firms track record includes public and private investments across industries and geographies, with a particular focus on technology-enabled businesses. Lyra Health has a post-money valuation in the range of $1B to $10B as of Jan 19, 2022 . In 2020, mental health startup funding was 5.5 times the $275 million investors ponied up four years earlier, according to data from CB Insights. Copyright 2023 CB Information Services, Inc. All rights reserved. Lyra Health is getting attention because of its . 2023 Lyra Health, Inc. works in partnership with Lyra Clinical Associates P.C. Lyra Health. Start Free Trial . Lyra Health doubles customers, expands to serve more than 2 million members. Lyra Health's 2020 revenue was $100M. LianBio collaborates with world-class partners across a diverse array of therapeutic and geographic areas to build out a pipeline based on disease relevance and the ability to impact patients with transformative mechanisms and precision-based therapeutics. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the clinical development, potential commercialization and potential benefits of LYR-210 and LYR-220, and the success of the companys strategic partnership and license agreement with LianBio. and other contracted partners to be your Lyra Care Navigator Team and deliver clinical services. Apr 18, 2022. U.S. Industry Overview & Market Statistics: INDEPENDENT SCHOOL GROUP LIFE & DISABILITY TRUST, Complete list of funding rounds and total amounts in the, EBIT (Earnings Before Interest and Taxes), Revenue from previous years (2010 to present), Funding from Venture Capital and Private Equity firms, Additional industries in which the company operates, What is the company's size? As part of the agreement, LianBio will also have the first right to obtain development and commercial rights in the licensed territories to Lyras LYR-220, an anti-inflammatory, intra-nasal, drug matrix in development for the treatment of CRS patients who have undergone a prior sinus surgery but continue to have persistent disease. Lyras XTreo platform is comprised of a biocompatible mesh scaffold, an engineered elastomeric matrix and a versatile polymer-drug complex. Lyra Health has 36 investors including Castlight Health, Providence, Castlight Health and Venrock Associates. Media Contact: Spring Health provides personalized mental healthcare for employees' well-being. Find related and similar companies as well as employees by title and much more. Tyler Gagnon, CanaleComm The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Their latest funding was raised on Jan 19, 2022 from a Series F round. 2023 Lyra Health, Inc. works in partnership with Lyra Clinical Associates P.C. Jan 28, 2021, 08:00 ET. For more information, visit lyrahealth.com and follow us onLinkedIn, Facebook, and Twitter. June 14, 2021 08:00 AM ET, BURLINGAME, Calif. Lyra Health, the leading provider of comprehensive mental health care benefits for employers, today announced it has completed a $200M financing. Lyra Health, a leading provider of innovative mental health benefits for more than 2.2 million global employees and dependents, is transforming mental health care by creating a frictionless experience for members, providers, and employers. Despite federal laws requiring mental health to be reimbursed at the same rates as physical illness, many people with insurance still face hurdles, from long wait times to denial of claims battles. & SHANGHAI & PRINCETON, N.J.--(BUSINESS WIRE)--Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo platform to enable precise, sustained, and local delivery of medications to ear, nose and throat (ENT) passages and other diseased tissues, and LianBio, a biotechnology company dedicated to bringing paradigm-shifting medicines to patients in China and other major Asian markets, today announced a strategic partnership and exclusive license agreement for the development and commercialization of LYR-210 in Greater China (mainland China, Hong Kong, Taiwan, and Macau), South Korea, Singapore and Thailand. 10 Fundings. This is the only company I've ever worked with, where we don't have to do marketing, says Kocher. "The traditional mental health care system cannot address the critical needs people have today. Using matching technology and an innovative digital platform, Lyra quickly connects companies and their employees plus spouses and children to world-class therapists, mental health coaches, and personalized medication prescribing. Funding, Valuation & Revenue. Calm started out as a direct-to-consumer mindfulness app with guided meditations and soothing soundtracks. Chrome Extension. The company was founded in 2017 and is based in San Francisco, California. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Innovative, Clinically Proven Mental Health Care for Members WorldwideLyra provides evidence-based care that supports people across all facets of mental health, from wellness and preventive care to the most severe conditions. Learn more. Lyra Health - Funding, Financials, Valuation & Investors - CrunchBase Lyra currently serves more than 2.2 million members globally. Coatue Management, Dragoneer Investment Group, and Salesforce Ventures, Coatue Management, Institutional Venture Partners, Sands Capital, and Undisclosed Investors, Addition, Baillie Gifford & Co., Durable Capital Partners, Fidelity Investments, Institutional Venture Partners, Sands Capital, and Undisclosed Investors. About Lyra HealthLyra Health, a leading provider of innovative mental health benefits for more than 2 million U.S. employees and dependents, is transforming mental health care by creating a frictionless experience for members, providers, and employers. It uses an assessment and machine-learning technology to understand all of the conditions of person may be experiencing and uses those results to match them to a care plan personalized to their needs. The company was formerly known as Happify Health and Happify. The Series F was led by Coatue and values the company at an astounding $4.6 billion. You can't just put a tool in an inequitable system and expect it to solve all of those inequities, says Nicole Martinez-Martin, an assistant professor at the Stanford Center for Biomedical Ethics who studies mental health apps. All rights reserved. Series E - Lyra Health - 2021-01-28 - CrunchBase Lyra is now able to directly support more than 2 million members as we enable employers to offer their people easy, effective access to clinically proven mental health care.
Roger Craig Smith Halo Infinite, Articles L